Is the IFN-alpha-related thyroid autoimmunity an immunologically heterogeneous disease?
D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D001327:Autoimmune Diseases / Q000209:etiology* / Q000235:genetics / Q000276:immunology; D015551:Autoimmunity / Q000235:genetics; D004359:Drug Therapy, Combination; D020022:Genetic Predisposition to Disease; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use; D013959:Thyroid Diseases / Q000209:etiology* / Q000235:genetics / Q000276:immunology; D013961:Thyroid Gland / Q000187:drug effects / Q000276:immunology*
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin